The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and clinical activity of MEDI4736, an anti-programmed cell death-ligand 1 (PD-L1) antibody, in patients with non-small cell lung cancer (NSCLC).
 
Naiyer A. Rizvi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; Roche Pharma AG
Research Funding - Bristol-Myers Squibb; MedImmune (Inst)
 
Julie R. Brahmer
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck KGaA
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
Other Relationship - Bristol-Myers Squibb
 
Sai-Hong Ignatius Ou
Honoraria - Pfizer
Consulting or Advisory Role - Pfizer; Roche Pharma AG
Speakers' Bureau - Boehringer Ingelheim; Roche Pharma AG
Research Funding - Astellas Pharma; AstraZeneca; Clovis Oncology; Pfizer
 
Neil Howard Segal
Consulting or Advisory Role - Bristol-Myers Squibb; MedImmune; Pfizer
Research Funding - Bristol-Myers Squibb; MedImmune; Pfizer
 
Samir Khleif
Leadership - Advaxis
Stock and Other Ownership Interests - Advaxis
Honoraria - Advaxis; AstraZeneca; MedImmune; Newlink Genetics
Consulting or Advisory Role - Advaxis; AstraZeneca; MedImmune; Newlink Genetics
Research Funding - Advaxis; AstraZeneca; MedImmune; Merck Serono; Newlink Genetics; PDS
Travel, Accommodations, Expenses - Advaxis; AstraZeneca; MedImmune; Novlik
 
Wen-Jen Hwu
Consulting or Advisory Role - Merck
Research Funding - MedImmune (Inst); Merck
 
Martin Gutierrez
Research Funding - Abbvie (Inst); Acceleron Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Esanex (Inst); Gilead Sciences (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); MedImmune (Inst); Novartis (Inst); Rexahn Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Patrick Schoffski
Honoraria - GlaxoSmithKline; Novartis; Prime Oncology; Swedish Orphan Biovitrum
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; GlaxoSmithKline; ITeos Therapeutics; Mundipharma; Novartis; PIQUR; Plexxikon; SERVIER; Swedish Orphan Biovitrum; Threshold Pharmaceuticals; ThromboGenics
Speakers' Bureau - GlaxoSmithKline; Novartis; Prime Oncology; Swedish Orphan Biovitrum
Research Funding - MedImmune (Inst); Novartis
 
Omid Hamid
Research Funding - MedImmune
 
Jared Weiss
Stock and Other Ownership Interests - Pharmacyclics
Consulting or Advisory Role - AstraZeneca; Biodesix; Clovis Oncology
Research Funding - Acceleron Pharma; Astellas Pharma; Celgene; GlaxoSmithKline; MedImmune; Pfizer
 
Jose Lutzky
Honoraria - Bristol-Myers Squibb; Genentech/Roche
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche
Research Funding - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Merck; Merck Serono; Millennium; Novartis; Onconova Therapeutics; Prometheus; Viralytics
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Prometheus
 
Michele Maio
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; MSD; Roche Pharma AG
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; MSD; Roche Pharma AG
Research Funding - Bristol-Myers Squibb; MedImmune
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; MSD; Roche Pharma AG
 
John J. Nemunaitis
Stock and Other Ownership Interests - Gradalis
Research Funding - MedImmune (Inst)
Patents, Royalties, Other Intellectual Property - Gradalis
 
Dirk Jaeger
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Roche Pharma AG
Research Funding - MedImmune (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Roche Pharma AG
 
Ani Sarkis Balmanoukian
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - MedImmune
Travel, Accommodations, Expenses - Caris MPI; Genentech
 
Marlon Rebelatto
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
Patents, Royalties, Other Intellectual Property - AstraZeneca (Inst)
 
Keith Steele
Employment - LCC (I); MedImmune
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I)
Patents, Royalties, Other Intellectual Property - MedImmune
 
Xia Li
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
John A. Blake-Haskins
Employment - MedImmune; MedImmune (I)
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I); GlaxoSmithKline; GlaxoSmithKline (I)
 
Scott Joseph Antonia
Honoraria - AstraZeneca; Bristol-Myers Squibb
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Research Funding - MedImmune (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb